Allogeneic Human Mesenchymal Stem Cells (hMSCs) Infusion in Patients With Treatment Resistant Depression
Status:
Terminated
Trial end date:
2019-03-26
Target enrollment:
Participant gender:
Summary
This study is intended to evaluate the safety and potential efficacy of Allogeneic Human
Mesenchymal Stem Cell Infusion versus placebo in patients with Treatment Resistant
Depression.